Form 8-K - Current report:
SEC Accession No. 0001689375-23-000008
Filing Date
2023-02-09
Accepted
2023-02-09 07:06:22
Documents
14
Period of Report
2023-02-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K trda-20230209.htm   iXBRL 8-K 39186
2 EX-99.1 trda-2023029pr.htm EX-99.1 11816
6 LOGO image_0a.jpg GRAPHIC 30141
  Complete submission text file 0001689375-23-000008.txt   238445

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20230209.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20230209_lab.xml EX-101.LAB 24927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20230209_pre.xml EX-101.PRE 13141
8 EXTRACTED XBRL INSTANCE DOCUMENT trda-20230209_htm.xml XML 11631
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 23601086
SIC: 2834 Pharmaceutical Preparations